Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Amgen reveals potent and selective typtase-inhibitory series

June 11, 1999

Cystic Fibrosis Foundation awards research grant to Genzyme

June 10, 1999

FDA says 3M's inhaled corticosteroid in CFC-free inhaler approvable for asthma

June 7, 1999

Kyowa Hakko presents new phosphodiesterase inhibitors

June 7, 1999

Inflazyme initiates phase I clinical trials with IPL-576092

June 4, 1999

Dual TxA2 and PGD2 antagonists from Shionogi

June 4, 1999

New PDE4 inhibitors with reduced emetogenic potential in the Kyowa Hakko pipeline

June 3, 1999

Sepracor and UCB reach Zyrtec isomer licensing agreement

June 3, 1999

Cell Therapeutics terminates enrollment in lung injury trial of lisofylline

June 2, 1999

Aradigm and Genentech sign development agreement for cystic fibrosis therapy

June 2, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...